Number of the records: 1
Adjuvant chemotherapy with bevacizumab (i.p.) can prolong survival time of patients with advanced ovarian cancer after cytoreduction
- Adjuvant chemotherapy with bevacizumab (i.p.) can prolong survival time of patients with advanced ovarian cancer after cytoreduction / F. Du ... [et al.] . Neoplasma : journal of experimental and clinical oncology. - ISSN 0028-2685 . - Vol. 64, no. 1 (2017), s. 108-113 : ilustr., grafy, tab.
- C 720
article
Number of the records: 1